| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0024-3205(67)90090-2 |
| P698 | PubMed publication ID | 4962200 |
| P2093 | author name string | Yang HY | |
| Erdos EG | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 569-574 | |
| P577 | publication date | 1967-03-01 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | An enzyme in microsomal fraction of kidney that inactivates bradykinin | |
| P478 | volume | 6 |
| Q72930589 | 37 Human peptidyl dipeptidase (converting enzyme, kininase II) |
| Q36849706 | A Cross-sectional Study of KLKB1 and PRCP Polymorphisms in Patient Samples with Cardiovascular Disease |
| Q24300463 | A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin |
| Q24306614 | A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme |
| Q39154011 | A rat kidney neutral peptidase that degrades B chain of insulin, glucagon, and ACTH: Purification by affinity chromatography and some properties |
| Q53595962 | ACE gene polymorphism might disclose why some Taiwanese children with allergic rhinitis develop asthma symptoms but others do not. |
| Q39938722 | Angiotensin I [Phe8-His9] hydrolase and bradykininase from human lung |
| Q33623829 | Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function |
| Q43056100 | Angiotensin II induces hyperresponsiveness of bronchial smooth muscle via an activation of p42/44 ERK in rats |
| Q38247932 | Angiotensin-I converting enzyme (ACE): structure, biological roles, and molecular basis for chloride ion dependence |
| Q38415486 | Association between angiotensin-converting enzyme I/D polymorphism and asthma risk: a meta-analysis involving 11,897 subjects |
| Q42167493 | Certain mouse strains are deficient in a kidney brush-border metallo-endopeptidase activity |
| Q54037130 | Cleavage of active peptides by a lung enzyme. |
| Q37883908 | Combination inhibition of the renin-angiotensin system: is more better? |
| Q66846278 | Conversion of angiotensin I to angiotensin II |
| Q72892058 | Converting-enzyme in the choroid plexus, brain, and kidney: Immunocytochemical and biochemical studies in rats |
| Q38360386 | Different glycosylation requirements for the synthesis of enzymatically active angiotensin-converting enzyme in mammalian cells and yeast |
| Q36997057 | Effect of SQ 14225, an inhibitor of angiotensin I-converting enzyme, on the granulomatous response to Schistosoma mansoni eggs in mice |
| Q28323054 | Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats |
| Q39977911 | Exopeptidases of the Nervous System |
| Q67291092 | Fluorometric assay of kininase activities in rat tissues |
| Q72996911 | High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma |
| Q70174643 | Human Converting Enzyme |
| Q36983789 | Inhibition of vascular permeability changes in rats by captopril |
| Q40025264 | Isolation of membrane-bound renal enzymes that metabolize kinins and angiotensins |
| Q39381976 | Joseph Rudinger memorial lecture: Unexpected functions of angiotensin converting enzyme, beyond its enzymatic activity |
| Q74180205 | Kinins, the long march--a personal view |
| Q47767180 | Metabolism of bradykinin by the rat coronary vascular bed. |
| Q37043907 | Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase |
| Q35665330 | Naturally occurring active N-domain of human angiotensin I-converting enzyme |
| Q37558988 | Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide |
| Q34206005 | New enzymatic route for the inactivation of angiotensin |
| Q41959976 | Novel activity of angiotensin-converting enzyme. Hydrolysis of cholecystokinin and gastrin analogues with release of the amidated C-terminal dipeptide |
| Q24294678 | Novel activity of human angiotensin I converting enzyme: release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone |
| Q39612684 | Preclinical studies on angiotensin converting enzyme inhibitors |
| Q43813264 | Prevalence of tumor necrosis factor-alpha and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma |
| Q28610229 | Purification and characterization of human converting enzyme (kininase II) |
| Q59078014 | Second Kininase in Human Blood Plasma |
| Q40025790 | Solubilization of angiotensin I-Converting enzyme from rabbit lung using trypsin treatment |
| Q42272545 | Species variation in the metabolism of 1-naphthylacetylglycylglycylglycine |
| Q27671388 | Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captopril |
| Q54526156 | Studies on the Mechanism of the Enhancement of the Antihypertensive Activity of Captopril by A Diuretic in Spontaneously Hypertensive Rats |
| Q40176847 | Subunits of human plasma kininase II generated by plasma kallikrein |
| Q40149755 | Sympathetic control of the renal circulation |
| Q59305166 | Synthesis, characterization and antioxidant activity of angiotensin converting enzyme inhibitors |
| Q37873387 | Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. |
| Q38177064 | The broad substrate specificity of human angiotensin I converting enzyme |
| Q70384745 | The juxtaglomerular apparatus in Bartter's syndrome and related tubulopathies. An immunocytochemical and electron microscopic study |
| Q35148421 | The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction |
| Q34209865 | The purification and specificity of a neutral endopeptidase from rabbit kidney brush border |
| Q35226612 | The release and fate of vaso-active hormones in the circulation |
| Q37588863 | The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system |
| Q40097569 | The surgical implications of nonrespiratory lung function |
| Q72917116 | Tripeptidyl carboxypeptidase activity of kininase II (angiotensin-converting enzyme) |
| Q53908060 | Type 1 angiotensin II receptor antagonism reduces antigen-induced airway reactions. |
Search more.